Induction of natural killer activity by Xanthenone analogues of flavone acetic acid: Relation with antitumour activity (Q67898492)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826446%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Induction of natural killer activity by xanthenone analogues of flavone acetic acid: relation with antitumour activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826446%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Induction of natural killer activity by Xanthenone analogues of flavone acetic acid: Relation with antitumour activity (English)

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

3 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

3 December 2022

author name string

L. M. Ching

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826446

3 December 2022

W. R. Joseph

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826446

3 December 2022

L. Zhuang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826446

3 December 2022

G. J. Atwell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826446

3 December 2022

G. W. Rewcastle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826446

3 December 2022

W. A. Denny

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826446

3 December 2022

B. C. Baguley

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826446

3 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1826446

3 December 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826446%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

18 September 2019

https://api.elsevier.com/content/article/PII:027753799190067N?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

https://api.elsevier.com/content/article/PII:027753799190067N?httpAccept=text/plain

3 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

European Journal of Cancer

3 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826446%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826446%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826446%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

79-83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826446%20AND%20SRC:MED&resulttype=core&format=json

Flavone acetic acid (LM 975, NSC 347512). A novel antitumor agent

18 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma

3 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

Effect of Flavone Acetic Acid on Lewis Lung Carcinoma: Evidence for an Indirect Effect1

3 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

Induction of natural killer cell activity by the antitumour compound flavone acetic acid (NSC 347 512).

3 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer

3 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

Enhancement of natural killer activity in human peripheral blood by flavone acetic acid

3 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

Immunomodulation of Natural Killer Cell Activity by Flavone Acetic Acid: Occurrence Via Induction of Interferon /beta

3 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo

3 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

Potential antitumor agents. 60. Relationships between structure and in vivo colon 38 activity for 5-substituted 9-oxoxanthene-4-acetic acids

3 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

Comparison of the effects of flavone acetic acid, fostriecin, homoharringtonine and tumour necrosis factor alpha on colon 38 tumours in mice

3 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

Effect of flavone acetic acid (NSC 347,512) on splenic cytotoxic effector cells and their role in tumour necrosis.

3 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

Reduction of cytotoxic effector cell activity in colon 38 tumours following treatment with flavone acetic acid

3 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

Enhancement of in vitro cytotoxicity of mouse peritoneal exudate cells by flavone acetic acid (NSC 347512)

3 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy.

3 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

Blood flow failure as a major determinant in the antitumor action of flavone acetic acid.

3 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

Hyporesponsiveness of macrophages from C3H/HeJ (endotoxin-resistant) mice to the antitumour agent flavone acetic acid (NSC 347512)

3 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells

3 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015)

3 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90067-N

3 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826446%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference